Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Exponent stock
Learn how to easily invest in Exponent stock.
Exponent Inc is a consulting services business based in the US. Exponent shares (EXPO) are listed on the NASDAQ and all prices are listed in US Dollars. Exponent employs 883 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Exponent
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – EXPO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Exponent stock price (NASDAQ: EXPO)Use our graph to track the performance of EXPO stocks over time.
Exponent shares at a glance
|Latest market close||$91.52|
|52-week range||$81.49 - $127.38|
|50-day moving average||$117.39|
|200-day moving average||$106.47|
|Wall St. target price||$130.50|
|Dividend yield||$0.79 (0.79%)|
|Earnings per share (TTM)||$1.93|
Buy Exponent shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Exponent stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Exponent price performance over time
|1 week (2022-01-14)||-9.56%|
|1 month (2021-12-22)||-23.74%|
|3 months (2021-10-22)||-19.40%|
|6 months (2021-07-22)||-1.27%|
|1 year (2021-01-22)||-1.84%|
|2 years (2020-01-22)||25.82%|
|3 years (2019-01-22)||77.57%|
|5 years (2017-01-20)||60.56%|
Is Exponent stock undervalued or overvalued?
Valuing Exponent stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Exponent's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Exponent's P/E ratio
Exponent's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 52x. In other words, Exponent shares trade at around 52x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Exponent's PEG ratio
Exponent's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.14. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Exponent's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Exponent's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $112 million.
The EBITDA is a measure of a Exponent's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$427.8 million|
|Operating margin TTM||24.63%|
|Gross profit TTM||$128.4 million|
|Return on assets TTM||11.23%|
|Return on equity TTM||27.44%|
|Market capitalisation||$5.3 billion|
TTM: trailing 12 months
Exponent share dividends
Dividend payout ratio: 44.2% of net profits
Recently Exponent has paid out, on average, around 44.2% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.79% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Exponent shareholders could enjoy a 0.79% return on their shares, in the form of dividend payments. In Exponent's case, that would currently equate to about $0.79 per share.
While Exponent's payout ratio might seem fairly standard, it's worth remembering that Exponent may be investing much of the rest of its net profits in future growth.
Exponent's most recent dividend payout was on 16 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 1 December 2021 (the "ex-dividend date").
Have Exponent's shares ever split?
Exponent's shares were split on a 2:1 basis on 7 June 2018. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Exponent shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Exponent shares which in turn could have impacted Exponent's share price.
Exponent share price volatility
Over the last 12 months, Exponent's shares have ranged in value from as little as $81.4884 up to $127.3848. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Exponent's is 0.3908. This would suggest that Exponent's shares are less volatile than average (for this exchange).
Exponent, Inc. , together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government.
Exponent in the news
Copeland Capital Management, LLC Buys Switch Inc, GFL Environmental Inc, Allison Transmission ...
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Leading Indian dancer Birju Maharaj dies
Frequently asked questionsWhat percentage of Exponent is owned by insiders or institutions?
Currently 1.161% of Exponent shares are held by insiders and 92.244% by institutions. How many people work for Exponent?
Latest data suggests 883 work at Exponent. When does the fiscal year end for Exponent?
Exponent's fiscal year ends in January. Where is Exponent based?
Exponent's address is: 149 Commonwealth Drive, Menlo Park, CA, United States, 94025 What is Exponent's ISIN number?
Exponent's international securities identification number is: US30214U1025 What is Exponent's CUSIP number?
Exponent's Committee on Uniform Securities Identification Procedures number is: 30214U102
More guides on Finder
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
Ask an Expert